Home › Atherosclerosis › Texas › McAllen
Atherosclerosis clinical trials in McAllen, TX
4 studies for Atherosclerosis are looking for participants at sites in and around McAllen (within about 30 miles). Open a study to see who can join and how to contact the study team.
Assessing the Impact of Muvalaplin on Major Cardiovascular Events in Adults With Elevated Lipoprotein(a)
RecruitingPhase 3
- Biopharma Informatic, LLC, McAllen
Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
RecruitingPhase 3
- Biopharma Informatic-McAllen, McAllen
Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)
RecruitingPhase 2/3
- Gamma Medical Research, Inc., McAllen
A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First Event
RecruitingPhase 3
- Research Site, McAllen
About Atherosclerosis
Atherosclerosis is hardening and narrowing of the arteries caused by the buildup of a fatty substance called plaque. Learn about the risks and prevention.
More about Atherosclerosis on MedlinePlus
Atherosclerosis trials in other cities
- Boston, MA10 studies
- Houston, TX10 studies
- Washington, DC9 studies
- Hialeah, FL8 studies
- Orlando, FL8 studies
- Arlington, VA8 studies
- Dallas, TX7 studies
- Durham, NC7 studies
- Las Vegas, NV7 studies
- Memphis, TN7 studies
- Miami, FL7 studies
- Amarillo, TX6 studies
Other studies in McAllen
- Macular Degeneration6 studies
- Metastatic Cancer5 studies
- Breast Cancer4 studies
- Diabetic Foot3 studies
- Heart Failure3 studies
- Geographic Atrophy3 studies
- Obesity3 studies
- Cardiovascular Disease3 studies
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.